Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
AZD4635（一种腺苷A2A受体拮抗剂）单药治疗或联合度伐利尤单抗治疗实体瘤患者的Ia/b期、开放标签、多中心研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-0612
Lim, Emerson A; Bendell, Johanna C; Falchook, Gerald S; Bauer, Todd M; Drake, Charles G; Choe, Jennifer H; George, Daniel J; Karlix, Janet L; Ulahannan, Susanna; Sachsenmeier, Kris F; Russell, Deanna L; Moorthy, Ganesh; Sidders, Ben S; Pilling, Elizabeth A; Chen, Huifang; Hattersley, Maureen M; Das, Mayukh; Kumar, Rakesh; Pouliot, Gayle P; Patel, Manish R
